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Malleret and colleagues show the importance of the bone marrow in Plasmodium vivax 
biology by proving the preferential infection of young reticulocytes, generally restricted 
to the bone marrow, which experience accelerated maturation post-invasion1. 
Plasmodium vivax mainly invades reticulocytes, a heterogeneous population of red 
blood cell precursors, characterized by a reticular network of residual RNA, whose 
maturation is indicated by the decreasing expression of the transferrin receptor CD71. 
This host cell specificity shapes P. vivax pathobiology and the strict requirement for 
reticulocytes has hampered the establishment of an in vitro culture system for this 
parasite. By sorting different developmental stages of cord blood reticulocytes for use 
in an ex vivo invasion assay, Malleret and colleagues show that P. vivax merozoites 
prefer the youngest of the young erythrocytes. The immature CD71+ reticulocytes, 
generally restricted to bone marrow, were more efficiently invaded than older CD71- 
reticulocytes, principally found in peripheral blood. This was puzzling, as P. vivax ring 
stage parasites from patients were instead predominantly found in CD71- reticulocytes.  
Analysing the first steps of P. vivax invasion of CD71+ reticulocytes, Malleret and 
colleagues revealed a remarkably rapid remodeling of P. vivax invaded reticulocytes, 
leading to increased deformability, accelerated loss of CD71 and replacement of 
clathrin pits by distinctive caveolae nanostructures. 
 
The narrow tropism towards CD71+ immature reticulocytes, produced and largely 
residing in the bone marrow2, raises the intriguing possibility that P. vivax invasion may 
mainly take place in this organ rather than in the circulating blood. The authors 
accordingly suggest that increased deformability associated with the accelerated 
reticulocyte aging might contribute to the trafficking of mature parasites into this organ 
and the egress of infected reticulocytes into the peripheral blood system. As pointed 
out in the paper, the accumulation of P. vivax infections in the bone marrow 
extravascular spaces may explain early observations of patients scored negative for P. 
vivax in peripheral blood but positive in bone marrow biopsies3. Several case reports 
described  recurrences  of P. vivax, as well as Plasmodium falciparum, following bone 
marrow transplantations4. Together with the evidences provided by Malleret and 
colleagues, these observations suggest that bone marrow can be a site where P. vivax 
parasites may hide and develop.  
 
Recent reports have placed the host-parasite interplay in the bone marrow at the 
center of pathophysiology and transmissibility of the other main human parasite P. 
falciparum by demonstrating the enrichment of late parasite stages and immature 
gametocytes in this organ, with the latter readily found in the bone marrow 
extravascular compartment 5-7. The current study shows the potential of the bone 
marrow as a niche where P. vivax invasion can occur before reentering the circulation. 
Intriguing similarities may deserve further attention. Most of the erythroid precursors 
containing P. falciparum immature gametocytes in the marrow stroma in autopsy 
specimens were CD71-7, suggesting a similar parasite-mediated acceleration of host 
cell differentiation. Moreover, the rapid increase in deformability of the P. vivax infected 
immature reticulocytes, proposed to facilitate migration through the bone marrow 
sinusoidal lining, parallels the analogous reduction in the rigidity of erythrocytes 
infected with P. falciparum mature sexual stages, which may help their release from the 
bone marrow sequestration sites to peripheral circulation8. 
 
The study by Malleret and colleagues raises several questions with far-reaching 
implications for P. vivax biology which may have clinical impact. First, what is the role 
of bone marrow as a reservoir of P. vivax parasites and what are the implications for 
strategies to eliminate malaria? The bone marrow is emerging as a site where both P. 
vivax and P. falciparum can hide and sustain infection and transmission, posing new 
challenges for malaria elimination initiatives directed at identifying and treating all 
Plasmodium infections. Second, through which mechanisms do infected reticulocytes 
transverse the bone marrow sinusoidal capillaries to the primary hematopoietic sinus? 
The authors argue that only young reticulocytes that have migrated out of the red bone 
marrow would be available for P. vivax invasion, unless invasion principally occurs in 
the extravascular space of the red bone marrow. The latter scenario would imply a two-
way journey of P. vivax merozoites and freshly invaded reticulocytes through the bone 
marrow sinusoidal capillaries, similarly to what has been proposed for P. falciparum7. 
Third, to what extent anaemia or inflammatory reactions, common during P. vivax 
infection, are triggered by the bone marrow tropism and might disrupt the sinusoidal 
lining permitting cellular transit? A relationship has been suggested between 
hematological disturbances and P. falciparum development in bone marrow5. This 
raises further questions on how this interplay in bone marrow is modified in the two 
parasite species once clinical malaria cease in asymptomatic infected individuals, as 
these will stand as the last, most challenging parasite reservoir to be attacked to 
achieve malaria eradication. Fourth, how does P. vivax accelerate reticulocyte aging? 
Do loss of the CD71 clathrin pits and the formation of microvesicles contribute to the 
rapid host cell remodeling, and are there common mechanisms to affect deformability 
of reticulocytes by P. vivax and of erythrocytes by P. falciparum gametocytes8? Finally, 
do parasites in the bone marrow reach some degree of refractoriness to treatment, as 
shown for Salmonella typhi9, malignant hematopoietic cells and epithelial tumor cells 
that metastasize to bone10? Investigating these topics will allow us to begin to dissect 
the role of the bone marrow in the P. vivax biology and the manifestation of disease. 
Bone marrow, which accounts for approximately 5% of the body weight in humans, 
generates all hematopoietic cells circulating in peripheral blood. Although functional 
alterations of the bone marrow under pathogen attacks are largely unknown, it is 
tempting to speculate that even small changes in this delicate environment may lead to 
significant modification in the cellular constituents in peripheral blood and tissues. An 
important role for bone marrow is emerging in the pathobiology of P. falciparum 
malaria. Malleret and colleagues expand a possibly similar role in P. vivax, requiring 
the assessment of how this organ contributes to the parasite biomass and the 
pathogenesis in this parasite. As for P. falciparum7, investigations of post mortem 
samples from P. vivax malaria cases would be of great value. 
 
Figure legend: Proposed models for P. vivax (A) and P. falciparum (B) development in 
the bone marrow.  A) Adapted from Malleret et al1. P. vivax infects stage III 
reticulocytes that have egressed by diapedesis to the sinusoidal capillary lumen. 
Alternatively, P. vivax merozoites or P. vivax-infected erythrocytes might enter the red 
bone marrow compartment leading to invasion of CD71+ reticulocytes. Accelerated 
reticulocyte aging increases host cell deformability for subsequent endothelial crossing 
towards blood circulation. B) Adapted from Joice et al7. Presence of immature 
gametocytes in the bone marrow extravascular space may be explained by 
erythrocytes infected by stage I gametocytes or sexually committed ring stages 
entering the bone marrow stroma through the endothelial lining. Alternatively, asexual 
schizonts which develop in the extravascular compartment may produce sexually 
committed merozoites invading erythroid precursors, whose host cell remodeling may 
share possible similarities with that of P. vivax. Mature gametocyte-infected host cells 
cross the endothelial barrier to reenter the circulation. Professional illustration by 
Patrick Lane, ScEYEnce Studios. 
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